MICHAEL WIEGERT: Open Payments
NPI 1104822592 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$80 in 5 payments from 5 companies in 2025. Trend: 2023 $182 · 2024 $282 · 2025 $80
Food & beverage: $80
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| Edwards Lifesciences Corporation | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: JARDIANCE, LEQVIO, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), NEXLETOL, FARXIGA.
Industry payments across NC — which companies pay providers there.
